Placebo response varies in antipsychotic drug trialsPlacebo response in clinical trials of antipsychotic medications is highly varied, which has implications for the design of placebo-controlled trials, according to a meta-analysis by Canadian investigators. Long-term rituximab cuts lymphoma recurrence risk Sponge-derived drug extends breast CA survival Eribulin among ‘handful’ of effective agents for metastatic disease Selenium a bust in lung cancer Supplement fails to prevent secondary tumour development Low-intensity activity helps recovery after stroke Extra arm exercises reduce depression, improve strength Rosiglitazone controversy continues to smolder Sildenafil fails to show benefit in pulmonary fibrosis patients Sticker puts doctors on guideline path Spray away premature ejaculation Aerosol anesthetic formulation impresses in phase III trials Addition of ambrisentan improves PAH outcomes First Previous 480 481 482 483 484 Next Last
